Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha
- PMID: 10798608
- DOI: 10.1023/a:1006694627907
Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha
Abstract
In the current study, increased interferon (IFN)-gamma, interleukin (IL)-10, and IL-12 p40 serum levels were observed in patients with chronic hepatitis C (CHC) compared to controls. Patients also displayed an increased spontaneous IFN-gamma release but a deficient peripheral blood mononuclear cells (PBMC) IFN-gamma production following stimulation with Staphylococcus aureus Cowan I strain (SAC). No difference was found with reference to spontaneous or phytohaemagglutinin (PHA)-induced IL-10 release between patients and controls, whereas a higher IL-12 p70 and IL-12 p40 secretion triggered by SAC was observed in patients. Moreover, IL-12 p40/p70 ratio following SAC stimulation was higher in patients compared to controls and a negative correlation was found between this ratio and IFN-gamma amounts. Recombinant IL-12 (rIL-12) as well as neutralizing anti-IL-10 monoclonal antibodies (mAbs) were able to restore the compromised IFN-gamma production. Of note, anti-IL-10 supplementation induced a lower IL-12 p40/p70 ratio in HCV subjects as compared to controls. Finally, IFN-alpha upregulated in vitro IFN-gamma, IL-10, and IL-12 p70 release but not IL-12 p40 secretion, this giving rise to a normalization of IL-12 p40/p70 ratio. The data suggest the occurrence of an enhanced responsiveness to IL-10 modulating effects, likely mediated by an imbalance of IL-12 p40/p70 ratio, in chronic HCV infection. Cytokine balance restoration might thus contribute to achieve therapeutical results in chronic hepatitis C.
Similar articles
-
Interleukin-12 p40/p70 ratio and in vivo responsiveness to IFN-alpha treatment in chronic hepatitis C.J Interferon Cytokine Res. 2001 Jul;21(7):453-61. doi: 10.1089/10799900152434303. J Interferon Cytokine Res. 2001. PMID: 11506737
-
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.J Exp Med. 1992 Nov 1;176(5):1387-98. doi: 10.1084/jem.176.5.1387. J Exp Med. 1992. PMID: 1357073 Free PMC article.
-
Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection.Immunol Lett. 2000 Oct 3;74(2):117-20. doi: 10.1016/s0165-2478(00)00210-8. Immunol Lett. 2000. PMID: 10996386
-
Relationship between T lymphocyte responsiveness and T-helper1/T-helper2 type cytokine release in chronic hepatitis C: a critical reappraisal.Microbios. 2001;106(415):203-12. Microbios. 2001. PMID: 11522131 Review.
-
Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).Clin Ter. 2006 Sep-Oct;157(5):457-68. Clin Ter. 2006. Retraction in: Clin Ter. 2008 May-Jun;159(3):208. PMID: 17147054 Retracted. Review.
Cited by
-
Hepatitis C virus modulates human monocyte-derived dendritic cells.J Viral Hepat. 2010 Nov;17(11):757-69. doi: 10.1111/j.1365-2893.2009.01231.x. J Viral Hepat. 2010. PMID: 20051006 Free PMC article.
-
Long Noncoding RNA AW112010 Promotes the Differentiation of Inflammatory T Cells by Suppressing IL-10 Expression through Histone Demethylation.J Immunol. 2020 Aug 15;205(4):987-993. doi: 10.4049/jimmunol.2000330. Epub 2020 Jul 20. J Immunol. 2020. PMID: 32690657 Free PMC article.
-
Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.World J Gastroenterol. 2010 Jun 7;16(21):2638-47. doi: 10.3748/wjg.v16.i21.2638. World J Gastroenterol. 2010. PMID: 20518086 Free PMC article. Clinical Trial.
-
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.J Clin Invest. 2009 Jul;119(7):1745-54. doi: 10.1172/JCI39133. Epub 2009 Jul 1. J Clin Invest. 2009. PMID: 19587449 Free PMC article. Review.
-
Immunogenic properties of a chimeric plant virus expressing a hepatitis C virus (HCV)-derived epitope: new prospects for an HCV vaccine.J Clin Immunol. 2005 Mar;25(2):142-52. doi: 10.1007/s10875-005-2820-4. J Clin Immunol. 2005. PMID: 15821891
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources